These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23414524)

  • 41. Autologous hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission: a meta-analysis of randomized trials.
    Wang J; Ouyang J; Zhou R; Chen B; Yang Y
    Acta Haematol; 2010; 124(2):61-71. PubMed ID: 20616541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of autologous hematopoietic cell transplantation and chemotherapy as postremission treatment in non-M3 acute myeloid leukemia in first complete remission.
    Usuki K; Kurosawa S; Uchida N; Yakushiji K; Waki F; Matsuishi E; Kagawa K; Furukawa T; Maeda Y; Shimoyama M; Ago H; Yamano Y; Yano S; Fujishima N; Takamatsu Y; Eto T; Hidaka M; Matsuoka H; Fukuda T
    Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):444-51. PubMed ID: 22999942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.
    Cook G; Clark RE; Crawley C; Mackinnon S; Russell N; Thomson K; Pearce RM; Towlson K; Marks DI
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):293-300. PubMed ID: 16503498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparable analysis of outcomes for allogeneic peripheral blood stem cell transplantation from matched related and matched unrelated donors in acute myeloid leukemia.
    Lee SJ; Kang BW; Moon JH; Chae YS; Kim JG; Jung JS; Cho GJ; Jo DY; Kim YK; Kim HJ; Ryoo HM; Eom HS; Lee SM; Joo YD; Won JH; Park MR; Kim MK; Hyun MS; Sohn SK
    Acta Haematol; 2012; 127(2):81-9. PubMed ID: 22143083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-Analysis.
    Li Z; Liu Y; Wang Q; Chen L; Ma L; Hao S
    Acta Haematol; 2019; 141(3):164-175. PubMed ID: 30808826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia.
    Sierra J; Martino R; Sánchez B; Piñana JL; Valcárcel D; Brunet S
    Bone Marrow Transplant; 2008 Mar; 41(5):425-37. PubMed ID: 18209727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors.
    Hows JM; Passweg JR; Tichelli A; Locasciulli A; Szydlo R; Bacigalupo A; Jacobson N; Ljungman P; Cornish J; Nunn A; Bradley B; Socié G; ;
    Bone Marrow Transplant; 2006 Dec; 38(12):799-805. PubMed ID: 17075568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission.
    Lorentino F; Labopin M; Bernardi M; Ciceri F; Socié G; Cornelissen JJ; Esteve J; Ruggeri A; Volin L; Yacoub-Agha I; Craddock C; Passweg J; Blaise D; Gedde-Dahl T; Poiani M; Fegueux N; Mohty M; Nagler A;
    Am J Hematol; 2018 Oct; 93(10):1236-1244. PubMed ID: 30058714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete Remission.
    Lv M; Wang Y; Chang YJ; Zhang XH; Xu LP; Jiang Q; Jiang H; Lu J; Chen H; Han W; Wang FR; Wang JZ; Chen Y; Yan CH; Zhang YY; Sun YQ; Mo XD; Zhu HH; Jia JS; Zhao T; Wang J; Liu KY; Huang XJ
    Clin Cancer Res; 2019 Mar; 25(6):1737-1748. PubMed ID: 30478089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMT.
    Chevallier P; Labopin M; Milpied N; Cornelissen JJ; Blaise D; Petersen E; Sandstedt A; Goker H; Socie G; Rocha V; Mohty M;
    Bone Marrow Transplant; 2012 Nov; 47(11):1442-7. PubMed ID: 22504932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison analysis between haplo identical stem cell transplantation and matched sibling donor stem cell transplantation for high-risk acute myeloid leukemia in first complete remission.
    Liu Y; Huang X; Fei Q; Xu L; Zhang X; Liu K; Chen Y; Chen H; Wang Y
    Sci China Life Sci; 2019 May; 62(5):691-697. PubMed ID: 30194676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard-risk acute lymphoblastic leukaemia in first complete remission.
    Han LJ; Wang Y; Fan ZP; Huang F; Zhou J; Fu YW; Qu H; Xuan L; Xu N; Ye JY; Bian ZL; Song YP; Huang XJ; Liu QF
    Br J Haematol; 2017 Oct; 179(1):120-130. PubMed ID: 28737249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma.
    El-Cheikh J; Crocchiolo R; Boher JM; Furst S; Stoppa AM; Ladaique P; Faucher C; Calmels B; Castagna L; Lemarie C; De Colella JM; Coso D; Bouabdallah R; Chabannon C; Blaise D
    Eur J Haematol; 2012 Jun; 88(6):497-503. PubMed ID: 22385049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allogeneic hematopoietic stem cell transplantation for intermediate-risk acute myeloid leukemia in the first remission: outcomes using haploidentical donors are similar to those using matched siblings.
    Ma YR; Xu LP; Zhang XH; Liu KY; Chang YJ; Lv M; Yan CH; Chen YH; Han W; Wang FR; Mo XD; Huang XJ; Wang Y
    Ann Hematol; 2021 Feb; 100(2):555-562. PubMed ID: 33415424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A.
    Schlenk RF; Döhner K; Mack S; Stoppel M; Király F; Götze K; Hartmann F; Horst HA; Koller E; Petzer A; Grimminger W; Kobbe G; Glasmacher A; Salwender H; Kirchen H; Haase D; Kremers S; Matzdorff A; Benner A; Döhner H
    J Clin Oncol; 2010 Oct; 28(30):4642-8. PubMed ID: 20805454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved survival for young acute leukemia patients following a new donor hierarchy for allogeneic hematopoietic stem cell transplantation: A phase III randomized controlled study.
    Zhang M; Xiao H; Shi J; Tan Y; Zhao Y; Yu J; Lai X; Hu Y; Zheng W; Luo Y; Huang H
    Am J Hematol; 2021 Nov; 96(11):1429-1440. PubMed ID: 34370319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis.
    Weisdorf D; Eapen M; Ruggeri A; Zhang MJ; Zhong X; Brunstein C; Ustun C; Rocha V; Gluckman E
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):816-22. PubMed ID: 24582782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remission.
    Hemmati PG; Schulze-Luckow A; Terwey TH; le Coutre P; Vuong LG; Dörken B; Arnold R
    Eur J Haematol; 2014 Feb; 92(2):102-10. PubMed ID: 24138573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories.
    Cornelissen JJ; Breems D; van Putten WL; Gratwohl AA; Passweg JR; Pabst T; Maertens J; Beverloo HB; van Marwijk Kooy M; Wijermans PW; Biemond BJ; Vellenga E; Verdonck LF; Ossenkoppele GJ; Löwenberg B
    J Clin Oncol; 2012 Jun; 30(17):2140-6. PubMed ID: 22564995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.